WebSep 21, 2024 · Package insert / product label. Generic name: cyclophosphamide. Dosage forms: injection, powder, for solution, tablets. Drug class: Alkylating agents. Medically reviewed by Drugs.com. Last … WebSep 30, 2024 · Oral CYTOXAN dosing is usually in the range of 1 to 5 mg/kg/day for both initial and maintenance dosing. Many other regimens of intravenous and oral CYTOXAN have been reported. Dosages must be adjusted in accord with evidence of antitumor activity and/or leukopenia. The total leukocyte count is a good, objective guide for regulating …
UpToDate
WebFeb 10, 2024 · This generalized information is a limited summary of diagnosis, treatment, and/or medication information. It is not meant to be comprehensive and should be used … WebOct 1, 2024 · Cyclophosphamide (CYC) is a chemotherapeutic agent with broad indications across solid organ and hematologic malignancies, ... Suggested surveillance regimens for patients following CYC have included monitoring for hematuria via urinalysis [1], but lack support from larger patient cohorts. We conducted a systematic review of … biography extract influential people
Cytoxan Oral: Uses, Side Effects, Interactions, Pictures ... - WebMD
WebCyclophosphamide is used alone or in combination with other medications to treat Hodgkin's lymphoma (Hodgkin's disease) and non-Hodgkin's lymphoma (types of cancer that begin in a type of white blood cells that normally fights infection); cutaneous T-cell lymphoma (CTCL, a group of cancers of the immune system that first appear as skin … WebDefinition. Hyponatremia is defined as a serum [Na+] <135 mmol/L and can be acute or chronic. The treatment of hyponatremia is guided by severity, chronicity, and etiology – so determination of all of these factors is paramount. Acute: <48 hours since development of hyponatremia. Chronic: >48 hours since development of hyponatremia. WebApr 5, 1995 · Results: A significant 4.5-fold risk of bladder cancer (95% confidence interval [CI] = 1.5-13.6) followed therapy with cyclophosphamide, and risk was dependent upon cumulative dose. Among patients who received a total amount of cyclophosphamide of less than 20 g, a nonsignificant 2.4-fold risk of bladder cancer was apparent. dailycast